All Stories

  1. Reverse vaccinology-based multi-epitope COVID-19 vaccine targeting SARS-CoV-2 structural and non-structural proteins induces immune responses in mice

    Article • Vaccine X, March 2025, Elsevier

    Nicholas Yamahoki

  2. Development of polyclonal chicken egg yolk immunoglobulin Y (IgY) antibodies targeting SARS-CoV-2 multi-epitope antigen

    Article • Journal of Virological Methods, January 2025, Elsevier

    Nicholas Yamahoki

  3. Development of Moloney Murine Leukemia Virus Reverse Transcriptase Fused with Archaeal DNA-binding Protein Sis7a

    Article • Recent Patents on Biotechnology, March 2024, Bentham Science Publishers

    Goldyna Marthasya Simanjuntak, Nicholas Yamahoki

  4. The SARS-CoV-2 Mpro Dimer-Based Screening System: A Synthetic Biology Tool for Identifying Compounds with Dimerization Inhibitory Potential

    Article • ACS Synthetic Biology, February 2024, American Chemical Society (ACS)

    Nicholas Yamahoki

  5. Porphyrin-derived carbon dots for an enhanced antiviral activity targeting the CTD of SARS-CoV-2 nucleocapsid

    Article • Journal of Genetic Engineering and Biotechnology, October 2023, Springer Science + Business Media

    Ferry Iskandar, Nicholas Yamahoki

  6. Curcumin-derived carbon-dots as a potential COVID-19 antiviral drug

    Article • Heliyon, September 2023, Elsevier

    Ferry Iskandar, Nicholas Yamahoki

  7. Analysis of SARS-CoV-2 Genomes from West Java, Indonesia

    Article • Viruses, October 2021, MDPI AG

    Nicholas Yamahoki